Business Context and Reporting Period
This Form 6-K filing by Brera Holdings PLC covers the month of September 2025, with the report dated September 5, 2025. The filing primarily addresses significant changes in executive leadership and board composition rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. No financial statements or operational metrics are included in this report.
Material Changes
- Executive Resignation: Pietro Bersani resigned as Chief Executive Officer (CEO) and Chief Financial Officer (CFO) effective September 3, 2025. The resignation was not due to any disagreement regarding operations, policies, or practices.
- New CEO/CFO Appointment: Dr. Fabio Scacciavillani was appointed as CEO and CFO effective September 3, 2025. He will continue as a director but will step down from the Audit, Compensation, and Nominating and Corporate Governance Committees, including his role as Audit Committee Chair.
- Board Restructuring: Abhishek Mathews, a current executive director, was appointed as an independent director and Chair of the Audit Committee, as well as a member of the Compensation and Nominating and Corporate Governance Committees.
Compensation and Agreements
Specific compensation terms were disclosed for the new appointments:
- Dr. Fabio Scacciavillani: Annual salary of $400,000 payable monthly; granted 30,000 Class B Ordinary Shares vesting equally over three years; eligible for a performance bonus at the Compensation Committee's discretion.
- Abhishek Mathews: Annual fee of $56,000 paid in four installments; granted 5,000 Class B Ordinary Shares vesting equally over three years.
Both individuals are covered under standard indemnification agreements, with the Company advancing preapproved expenses within 10 business days.
Investor Verification Checklist
- Verify the transition plan for financial reporting and operational oversight following the simultaneous resignation of the CEO and CFO.
- Confirm the impact of Dr. Scacciavillani's removal from the Audit Committee on the company's internal controls and governance structure.
- Review the attached Exhibits 1.1 and 1.2 for full details on the consulting and independent director agreements.
- Monitor future filings for the first financial results under the new leadership team.